BreastScreening-AI
Founded 2024
About BreastScreening-AI
What is BreastScreening-AI? BreastScreening-AI focuses on developing an advanced AI-powered system capable of analyzing mammograms, MRI scans, and ultrasound images for the early detection of breast cancer. The integration of multiple imaging modalities enables our AI tool, named multimodality CNNs (MMCNNs), to process information in a comprehensive and unified manner. Why BreastScreening-AI? Breast cancer is a significant global health concern, and early detection is crucial for effective treatment. Unfortunately, conventional screening methods sometimes result in False Negative and False-Positive results, leading to delayed diagnosis or unnecessary biopsies. BreastScreening-AI aims to address these challenges by providing accurate and reliable diagnostic assistance to radiologists, clinicians, and hospitals. Our Vision BreastScreening-AI envisions a future where early breast cancer detection is no longer an elusive goal. By leveraging cutting-edge AI technology and collaborating with medical experts, we strive to make breast cancer screening more accessible, accurate, and efficient for healthcare providers worldwide. Join us on this transformative journey to save lives and make a lasting impact on breast cancer detection. Together, we can create a world where early diagnosis becomes a reality, leading to better patient outcomes and an improved quality of life for countless individuals.
Company Facts
- Founded: 2024
- Legal name: SensiPerception, LDA
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: breastscreeningai.com
- Phone: +351914818105
Social Profiles
Canonical: https://fsome.com/organization/breastscreening-ai-8283302 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.